- ongoing, recruitingTherapeutic exploratory (Phase II)
Safety and Efficacy of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Candidemia
This study is checking a new treatment called Immukine alongside usual care for a serious fungal infection in the blood called candidemia. Researchers want to see if it makes people get better faster and how safe it is.
Netherlands · Greece · Romania - authorisedTherapeutic use (Phase IV)
A multicenter, randomized, double-blind, placebo-controlled, adaptive, non-inferiority trial to investigate shortening treatment duration in uncomplicated candidemia: the CanTEN trial
This study, CanTEN, is looking at how long we need to treat a serious fungal infection called candidemia. It compares standard treatment with a shorter course, using common medicines like caspofungin, to see if shorter treatment is just as good and safe for patients.
Germany